Author:
Gouda Mohamed A.,Subbiah Vivek
Reference83 articles.
1. FDA approvals of oncology drugs for tissue-agnostic indications;Zettler;Target Oncol,2023
2. Tumor-Agnostic Precision Medicine from the AACR GENIE Database: Clinical Implications;Gouda;Clin Cancer Res,2023
3. RETEVMO® (selpercatinib) capsules, for oral use: FDA Packaging Insert.
4. TAFINLAR® (dabrafenib) capsules, for oral use,2022
5. MEKINIST® (trametinib) tablets, for oral use,2022